Literature DB >> 32419432

Diastolic dysfunction of the left ventricle - a practical approach for an anaesthetist.

Mateusz Zawadka1, Michał Marchel2, Paweł Andruszkiewicz1.   

Abstract

Bedside point-of-care echocardiography is being increasingly incorporated in peri-operative assessment and in intensive care units. Because of availability of tissue Doppler imaging in the modern ultrasound machines there has been an increased interest in research of diastolic function of left ventricle. The diastolic function is crucial for the hemodynamically effective function of the heart. Diastolic dysfunction is a well-established risk factor of the major adverse cardiac events during perioperative period, complications during weaning from ventilator and prognostic factor of mortality in septic shock.

Entities:  

Keywords:  HfpEF; TDI; bedside echocardiography; diastology; echocardiography; heart failure; point of care; tissue Doppler; diastolic dysfunction

Year:  2020        PMID: 32419432     DOI: 10.5114/ait.2020.94486

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  4 in total

1.  The impact of ultrasound-guided recruitment maneuvers on the risk of postoperative pulmonary complications in patients undergoing general anesthesia.

Authors:  Jolanta Cylwik; Natalia Buda
Journal:  J Ultrason       Date:  2022-02-08

2.  Lung Ultrasonography in the Monitoring of Intraoperative Recruitment Maneuvers.

Authors:  Jolanta Cylwik; Natalia Buda
Journal:  Diagnostics (Basel)       Date:  2021-02-10

3.  Pre-operative point-of-care assessment of left ventricular diastolic dysfunction, an observational study.

Authors:  Ylva Stenberg; Ylva Rhodin; Anne Lindberg; Roman Aroch; Magnus Hultin; Jakob Walldén; Tomi Myrberg
Journal:  BMC Anesthesiol       Date:  2022-04-05       Impact factor: 2.217

4.  Factors associated with left ventricular diastolic dysfunction in patients with septic shock.

Authors:  Wei-Dong Ge; Feng-Zhi Li; Bang-Chuan Hu; Li-Hong Wang; Ding-Yuan Ren
Journal:  Eur J Med Res       Date:  2022-07-27       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.